Search
atoltivimab; atoltivimab
Indications:
- treatment of infection caused by Zaire Ebola virus in combination with maftivimab & odesivimab (Inmazeb)
Dosage:
injection 16.7 mg/mL
Interactions
drug adverse effects of pharmaceutical monoclonal antibodies
General
pharmaceutical monoclonal antibody
antiviral agent
References
- Mayo Clinic:
Atoltivimab, Maftivimab, and Odesivimab-Ebgn (intravenous route)
https://www.mayoclinic.org/drugs-supplements/atoltivimab-maftivimab-and-odesivimab-ebgn-intravenous-route/description/drg-20503601
- Regeneron
INMAZEB atoltivimab, maftivimab, and odesivimab-ebgn) INJECTION
https://www.regeneron.com/inmazeb-injection
- RxNorm
Component-of
atoltivimab/maftivimab/odesivimab-egbn (Inmazeb)